Cellular senescence — where aging cells stop dividing and release harmful signals — is a major driver of tissue decline and age-related disease. Not all senescent cells are alike, though. New research published in Aging Cell compared two types: primary senescent cells triggered by radiation damage, and secondary senescent cells created when the inflammatory signals from already-senescent cells (called SASP) convert healthy neighbors. The study found these two types differ significantly in behavior and biology. Understanding this distinction matters because treatments targeting senescent cells — called senolytics — may need to be tailored depending on which type is present. This research adds important nuance to how we think about clearing or neutralizing senescent cells as a strategy for extending healthy lifespan.
